65,437 trials
Non-Small Cell Lung Cancer
Primary: Overall Survival (OS) — 10.3; 9.2 Months — p=0.025
Glaucoma · Angle-Closure
Primary: Percentage of Participants Achieving at Least a 20% Reduction From Baseline Hour 0 IOP While on the Same Number or Fewer IOP Lowering Medications at Month 12 — 80.5…
Osteoarthritis, Knee / Osteoarthritis, Hip
Primary: WOMAC Pain Score (Change From Baseline at Week 16) — -1.74; -2.96; -1.78; -2.12 units on a scale — p=<0.001
Peripheral Neuropathy · Diabetes
Primary: Body Mass Index (BMI) — 30.7 kg/m^2
Low Back Pain
Primary: Spinal Stiffness — 6.20; 6.28; 6.10; 6.07 N/mm — p=0.025
Bipolar Depression
Primary: Change From Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score — -16.2; -16.9; -14.5 score on a scale — p=0.021
Migraine Headache
Primary: Reduction in Days of Headache Pain With Treatment of Memantine or Valproate in the Preventive Management of Episodic Migraine. — 5.35; 5.31; 0.77; 0.93 Migraine days by…
Type 1 Diabetes
Primary: Percent of Time With Sensed Glucose <70 mg/dl — 2.5; 1.3 percentage of time
COVID-19
Primary: Severity of COVID-19: Evaluation of the Severity of COVID-19 as Measured by the Maximum Difference From the Baseline Value in the OSCI Within 28 Days From the Start of…
Hearing Loss
Primary: Electroacoustic Evaluation of Hearing Aids in Accordance With Manufacturer Specifications, Day 1 — 38; 0 hearing aid devices
Breast Cancer
Primary: The Radiation Dose in Gy to the Heart and Lung Using Two Radiation Techniques. — 0.9317; 0.7186; 0.6523; 0.8746 Gy — p==0.0063
Type 1 Diabetes
Primary: Time in Range (TIR) 70-180 mg/dL From Breakfast Time + 5 Hours — 58; 63; 75 percentage of time
Erythema · Sensitisation
Primary: Evidence of Erythema During the Challenge Phase for Omeza Collagen Matrix — 53; 49; 0; 4 Participants
Diabetes Mellitus, Type 1
Primary: Glutathione Concentration — 706; 734 umol/L
Dementia, Vascular · Alzheimer Dementia · Lewy Body Dementia With Behavioral Disturbance
Primary: Caregiver Activity Survey — 305.7 minutes